Low-Serum Vero Cell Medium for FBS-Free Virus Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional vaccine production using animal-derived serum in Vero cell culture faces challenges such as variability, high cost, risk of infection, and complexity, necessitating a serum-reduced or serum-free medium for Vero cell culture.
Innovation Solution
A medium composition for Vero cells comprising 1-7% newborn calf serum (NCS), 1-6 g/L hydrolysate, and 1-6 mg/L insulin, which promotes cell adhesion and growth without fetal bovine serum (FBS).
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fetal bovine serum (FBS) is used in Vero cell culture medium, then cell adhesion and growth are promoted, but product uniformity deteriorates and risk of pathogen infection increases
Solution Approach 1:
The patent removes FBS from the culture medium and replaces it with a defined composition containing newborn calf serum (NCS), hydrolysate, and insulin. This extraction eliminates the pathogen infection risk associated with FBS while maintaining cell growth promotion through the alternative serum-free composition.
Solution Approach 2:
The patent changes the chemical composition parameters of the culture medium by substituting FBS with a specific combination of NCS (1-7%), hydrolysate (1-6 g/L), and insulin (1-6 mg/L). This parameter change achieves serum reduction while maintaining reliable cell growth and eliminating pathogen risks.
2Ease of operation
If fetal bovine serum (FBS) is used in Vero cell culture medium, then cell adhesion is facilitated, but manufacturing complexity increases
Solution Approach 1:
The patent extracts FBS from the medium and replaces it with a defined composition of NCS, hydrolysate, and insulin. This simplifies the downstream processing by eliminating the complexity associated with FBS handling, storage, and quality control while maintaining cell adhesion facilitation.
Solution Approach 2:
The patent changes the medium composition to a defined serum-free formulation with specific concentrations of NCS, hydrolysate, and insulin. This parameter change reduces manufacturing complexity by providing a more stable and predictable composition compared to FBS-based media.
3Productivity
If fetal bovine serum (FBS) is used in Vero cell culture medium, then cell growth is promoted, but production cost increases
Solution Approach 1:
The patent removes expensive FBS from the medium and replaces it with a cost-effective combination of NCS, hydrolysate, and insulin. This substitution maintains cell proliferation rate while significantly reducing the cost per unit of culture medium.
Solution Approach 2:
The patent employs a cost-effective medium composition using affordable components like NCS and hydrolysate instead of expensive FBS. This approach reduces the quantity of expensive substances required while maintaining high cell productivity.
Data Source
AI summary
The present invention relates to a low-serum medium composition for culturing Vero cells, and a method for culturing Vero cells and a method for producing a virus, both using the same.